BioCentury
ARTICLE | Clinical News

Thalidomide: Partner Bristol-Myers Squibb began two small Phase II trials with thalidomide

April 8, 1996 7:00 AM UTC

EntreMed Inc., Rockville, Md. Product: Thalidomide Indication: Anti-angiogenesis for cancer and Kaposi's sarcoma Status: Partner Bristol-Myers Squibb began two small Phase II trials with thalidomide ...